WallStreetZenWallStreetZen

NASDAQ: IMVT
Immunovant Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immunovant earnings were -$413.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IMVT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$106.4M, down 4.2% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, IMVT reported annual earnings of -$413.8M, with 59.6% growth.

IMVT earnings history

Current Revenue
$0.0
Current Earnings
-$413.8M
Current Profit Margin
0%

IMVT Return on Equity

Current Company
-80.6%
Current Industry
-60.2%
Current Market
31.5%
IMVT's Return on Equity (-80.6%)... subscribe to Premium to read more.
High Return on Equity Performance

IMVT undefined

Current Company
-71.9%
Current Industry
-2.5%
IMVT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMVT announces earnings.

IMVT undefined

Current Company
-58.37%
Current Industry
5.8%
IMVT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMVT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMVT-$412.44M-$413.84MN/A-$2.73
APGE-$202.64M-$205.39MN/A-$3.60
IBRX-$240.81M-$409.10MN/A-$0.54
AAPG-$32.47M-$55.46MN/A-$0.73
MLTX-$145.71M-$147.83MN/A-$2.30
View Top Biotech Stocks

Immunovant Earnings Reports & History FAQ

What were Immunovant's earnings last quarter?

Immunovant (NASDAQ: IMVT) reported Q1 2025 earnings per share (EPS) of -$0.63, up 21.15% year over year. Total IMVT earnings for the quarter were -$106.45 million. In the same quarter last year, Immunovant's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Immunovant stock.

Is Immunovant profitable or losing money?

As of the last Immunovant earnings report, Immunovant is currently losing money. Immunovant's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$413.84 million, a 59.58% increase year over year.

What was IMVT's earnings growth in the past year?

As of Immunovant's earnings date in Q2 2025, Immunovant's earnings has grown year over year. IMVT earnings in the past year totalled -$413.84 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.